Clinical Trial Update: Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 study assessing consolidation with busulfan and melphalan plus autologous stem cell transplant after chemotherapy in newly diagnosed high-risk neuroblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Neuroblastoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Melphalan (Melphalan)

Snippet

Sponsor: Children's Oncology Group | Conditions: Ganglioneuroblastoma, Stage 1 Neuroblastoma | Phase 1 | Status: COMPLETED | Results posted: 2017-02-09